Amneal stock: buy or sell?
April 2nd, 2020
Should I buy Amneal stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Amneal stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Amneal Pharmaceuticals stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't find any rating for AMRX stock for the last 30 days.
Amneal stock analysis
After sliding a bloodcurdling -14.85% yesterday, Amneal closed today at $3.05 and grew a tiny 0.66%.
After sliding a bloodcurdling -14.85% yesterday, Amneal closed today at $3.05 and grew a tiny 0.66%. Since March/20 when SMA100d and SMA200d crossed up, AMRX price slipped $-0.14 per share (-4.39%). AMRX is retaking the upward trend marking a new rising bottom heading to break out over $4.38.
After sliding a chilling -19.00% in a week last week, Amneal closed this week at $3.05 and grew a good 1.67%. By mid March AMRX boosted an outstanding 15.13% in just one week.
Since SMA20w and SMA40w crossed up early March, AMRX price slid a -20.78%. Since price and 40-weeks moving average lines crossed down late February, AMRX fell $-1.60 per share (-34.41%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.
Amneal stock price history
Amneal IPO was on May 7th, 2018 at $17.00 per share1. Since then, AMRX stock declined a -82.10%, with a yearly average of -82.10%.
1: Adjusted price after possible price splits or reverse-splits.
Amneal stock historical price chart
AMRX stock reached 52-week highs at $14.65, and all-time highs 2018-08-22 with a price of 24.48.
Amneal stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price prediction for Amneal Pharmaceuticals stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareSince May, when Amneal presented its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw an exceptional increase of 60.89% to $1,662.99 M USD. When comparing 2018 vs 2017, nevertheless, profit margin (that is, the net income divided by revenues) slightly fell a -1.26% to -1.26%. To have an updated picture of the financial situation of Amneal Pharmaceuticals, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Amneal Pharmaceuticals TTM sales up to were $1,387.80 and earnings were $-20.92 million dollars. If we compare this TTM figures with the last reported annuality, we can esteem Amneal business evolution since December 2018: Annual revenues up to , compared to lastest yearly report, plummed a spooky -16.55%. Nevertheless, profit margin (net income/revenues) stayed constant at -1.26%.
|2013||$512 M||-||$101 M19.8%||-|
|2014||$596 M||16.53%||$57 M9.6%||-43.36%|
|2015||$860 M||44.36%||$39 M4.5%||-32.00%|
|2016||$1,018 M||18.33%||$0.00 M0.0%||-100.00%|
|2017||$1,034 M||1.52%||$0.00 M0.0%||0.00%|
|2018||$1,663 M||60.89%||$-20.92 M-1.3%||0.00%|
|TTM||$1,388 M||-16.55%||$-20.92 M-1.5%||0.00%|
Quarterly financial resultsAmneal Pharmaceuticals posted million in sales for 2019-Q1, a -100.00% decline compared to previous quarter. Reported quarter income marked million with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was -1.76%. When comparing revenues to same quarter last year, Amneal sales marked a neutral movement and stayed stable a nan%.
|2017-Q1||$184 M||-||$-98.43 M-53.4%||-|
|2017-Q2||$260 M||40.93%||$37.45 M14.4%||-138.04%|
|2017-Q3||$255 M||-1.98%||$0.00 M0.0%||-100.00%|
|2017-Q4||$183 M||-28.20%||$-301.07 M-164.6%||0.00%|
|2018-Q2||$414 M||126.22%||$-19.10 M-4.6%||-93.65%|
|2018-Q3||$476 M||15.15%||$6.95 M1.5%||-136.39%|
|2018-Q4||$498 M||4.42%||$-8.77 M-1.8%||-226.12%|
Amneal ownershipWhen you are planning to buy shares of a company, it's always worth to check its ownership structure.
Amneal shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 12.76% of all shares.
In case of Amneal stock, 69.48% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AMRX stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related companies:
|Market cap||$449.3 M|
|Total shares||147.3 M|
|Float shares||94.4 M|
|- Institutional holdings (%)||69.5%|
|- Insider holdings (%)||12.8%|
|Shares in short selling||0.0%|
|Thursday, April 2nd, 2020|
|Day range||$2.91 - $3.18|
|Average true range||$0.52|
|50d mov avg||$4.01|
|100d mov avg||$4.06|
|200d mov avg||$3.85|
Amneal performanceTo measure stock performance is always good to compare with competitors or related stocks. We compared Amneal against in the following table: